Twirla - A New Contraceptive Patch
Date: February 8, 2021
Issue #:
1617Summary:
The FDA has approvedTwirla (Agile Therapeutics),
a transdermal contraceptive patch containing the
estrogen ethinyl estradiol and the progestin
levonorgestrel, for use in women with a BMI<30 kg/m2.
It is the second contraceptive patch to become
available in the US;Xulane, a patch that delivers
ethinyl estradiol and the progestin norelgestromin,
has been available since 2014.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: admin Tags: Contraceptives Estrogens Evra IUD Levonorgestrel Nexplanon ombitasvir Oral contraceptives paritaprevir Progestins Ritonavir Technivie Twirla Viekira Pak Xulane Source Type: research